Sternal wound infection after coronary artery bypass graft surgery: Validation of existing risk scores

Journal of Thoracic and Cardiovascular Surgery

Volumn 133, Issue 2, 2007, Pages 397-403

  Paul, Mical ^a   Raz, Aeyal ^a   Leibovici, Leonard ^a   Madar, Hefziba ^a   Holinger, Rita ^a   Rubinovitch, Bina ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; EVALUATION; FEMALE; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDIASTINITIS; MORTALITY; PERCEPTIVE DISCRIMINATION; POSTOPERATIVE COMPLICATION; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RISK; RISK ASSESSMENT; SCORING SYSTEM; STERNUM; STRATIFICATION; SURGEON; VALIDATION PROCESS;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COHORT STUDIES; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC; STERNUM; SURGICAL WOUND INFECTION;

EID: 33846508135     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2006.10.012     Document Type: Article

References (27)

1. Coskun D., Aytac J., Aydinli A., and Bayer A. Mortality rate, length of stay and extra cost of sternal surgical site infections following coronary artery bypass grafting in a private medical centre in Turkey. J Hosp Infect 60 (2005) 176-179
2. Fowler Jr. V.G., O'Brien S.M., Muhlbaier L.H., Corey G.R., Ferguson T.B., and Peterson E.D. Clinical predictors of major infections after cardiac surgery. Circulation 112 suppl (2005) I358-I365
3. Toumpoulis I.K., Anagnostopoulos C.E., Derose Jr. J.J., and Swistel D.G. The impact of deep sternal wound infection on long-term survival after coronary artery bypass grafting. Chest 127 (2005) 464-471
4. National Nosocomial Infections Surveillance (NNIS) System Report. Data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32 (2004) 470-485
5. Berman M., Stamler A., Sahar G., Georghiou G.P., Sharoni E., Brauner R., et al. Validation of the 2000 Bernstein-Parsonnet score versus the EuroSCORE as a prognostic tool in cardiac surgery. Ann Thorac Surg 81 (2006) 537-540
6. Nashef S.A., Roques F., Michel P., Gauducheau E., Lemeshow S., and Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16 (1999) 9-13
7. Nashef S.A., Roques F., Hammill B.G., Peterson E.D., Michel P., Grover F.L., et al. Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg 22 (2002) 101-105
8. Yap C.H., Reid C., Yii M., Rowland M.A., Mohajeri M., Skillington P.D., et al. Validation of the EuroSCORE model in Australia. Eur J Cardiothorac Surg 29 (2006) 441-446
9. Toumpoulis I.K., Anagnostopoulos C.E., DeRose J.J., and Swistel D.G. Does EuroSCORE predict length of stay and specific postoperative complications after coronary artery bypass grafting?. Int J Cardiol 105 (2005) 19-25
10. Roques F., Nashef S.A., Michel P., Gauducheau E., de Vincentiis C., Baudet E., et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 15 (1999) 816-822
11. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections, 1988. Am J Infect Control 16 (1988) 128-140
12. Roques F., Nashef S.A., Michel P., Pinna Pintor P., David M., Baudet E., et al. Does EuroSCORE work in individual European countries?. Eur J Cardiothorac Surg 18 (2000) 27-30
13. Bratzler D.W., and Houck P.M. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 38 (2004) 1706-1715
14. Kluytmans J.A., Mouton J.W., VandenBergh M.F., Manders M.J., Maat A.P., Wagenvoort J.H., et al. Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 17 (1996) 780-785
15. Nicholson M.R., and Huesman L.A. Controlling the usage of intranasal mupirocin does impact the rate of Staphylococcus aureus deep sternal wound infections in cardiac surgery patients. Am J Infect Control 34 (2006) 44-48
16. Carr J.M., Sellke F.W., Fey M., Doyle M.J., Krempin J.A., de la Torre R., et al. Implementing tight glucose control after coronary artery bypass surgery. Ann Thorac Surg 80 (2005) 902-909
17. Furnary A.P., Zerr K.J., Grunkemeier G.L., and Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 67 (1999) 352-360
18. Furnary A.P., Gao G., Grunkemeier G.L., Wu Y., Zerr K.J., Bookin S.O., et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125 (2003) 1007-1021
19. Hruska L.A., Smith J.M., Hendy M.P., Fritz V.L., and McAdams S. Continuous insulin infusion reduces infectious complications in diabetics following coronary surgery. J Card Surg 20 (2005) 403-407
20. Lazar H.L., Chipkin S.R., Fitzgerald C.A., Bao Y., Cabral H., and Apstein C.S. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 109 (2004) 1497-1502
21. Mangram A.J., Horan T.C., Pearson M.L., Silver L.C., and Jarvis W.R. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 27 (1999) 97-132
22. Bolon M.K., Morlote M., Weber S.G., Koplan B., Carmeli Y., and Wright S.B. Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clin Infect Dis 38 (2004) 1357-1363
23. Finkelstein R., Rabino G., Mashiah T., Bar-El Y., Adler Z., Kertzman V., et al. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. J Thorac Cardiovasc Surg 123 (2002) 326-332
24. Caffarelli A.D., Holden J.P., Baron E.J., Lemmens H.J., D'Souza H., Yau V., et al. Plasma cefazolin levels during cardiovascular surgery: effects of cardiopulmonary bypass and profound hypothermic circulatory arrest. J Thorac Cardiovasc Surg 131 (2006) 1338-1343
25. Berger P.B., Velianou J.L., Aslanidou Vlachos H., Feit F., Jacobs A.K., Faxon D.P., et al. Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy. Results from the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 38 (2001) 1440-1449
26. Serruys P.W., Unger F., Sousa J.E., Jatene A., Bonnier H.J., Schonberger J.P., et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 344 (2001) 1117-1124
27. Zhang Z., Mahoney E.M., Stables R.H., Booth J., Nugara F., Spertus J.A., et al. Disease-specific health status after stent-assisted percutaneous coronary intervention and coronary artery bypass surgery: one-year results from the Stent or Surgery trial. Circulation 108 (2003) 1694-1700